For example, the anti-CD117 (c-kit) antibody may be classified as Class I (if it is used to diagnose a neoplasm, eg, gastrointestinal stromal tumor (GIST)) or Class III (if its expression by GIST must be demonstrated to qualify the patient for imatinib therapy). This evidence concerns the gene KIT and neoplasm.